{"name":"Nirsum Labs","slug":"nirsum-labs","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQSUU4UWQybFMybHlTd040MEpDTVRoSFc5TzFBdVpNbXVHWFVYWkRabkQyNUR5NzE3cDdaeUxYZmY5ejUwMzlyMzc2eTVGMXdhdEVFZFNkMW11MWtmS01KUjRNdGJaQklLdDZ3LWRaY0RMT1RSbXE1UmZxeVpSdWVSTjBnRXFXbmZ0TEVfYjZaSktvZjl2MU9aZGFnQXRLX2F3UWZqS3JCOGw?oc=5","date":"2024-12-19","type":"pipeline","source":"Contract Pharma","summary":"Lifecore Biomedical to Provide CDMO Services to Nirsum Labs - Contract Pharma","headline":"Lifecore Biomedical to Provide CDMO Services to Nirsum Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNV0hiczlSV01UTmRGa2pFSVFmVndna2dCVzlFcWdrUC1GOEZWQXhBVnpyNjh1amtUelV0VUlOLU9rTXJRb19oVUxjMk05RElXY3VCczMzZHN1SnZJeTlLdVZxdjBNYVJ2ekYyWm1Ta0dnUzZ0aEVBSjNhWkg3bEx3SnMyaEIxVGRlUUZEOV80VUludzNWM0FZRkt1b20wM2pQVU91NWZMQkN6c2taeGxrdzFBMkoyMTNyaVVBWk40ZDA?oc=5","date":"2024-12-19","type":"deal","source":"Stock Titan","summary":"Lifecore Biomedical Lands Key CDMO Partnership for Novel Addiction Treatment Drug Development - Stock Titan","headline":"Lifecore Biomedical Lands Key CDMO Partnership for Novel Addiction Treatment Drug Development","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}